Affect lability and Enterocolitis

Summary:

Enterocolitis is reported only by a few people with Affect lability.

The study analyzes which people have Enterocolitis with Affect lability. It is created by eHealthMe based on 1 person who has Enterocolitis and Affect lability from the Food and Drug Administration (FDA), and is updated regularly.

What is Affect lability?

Affect lability (emotional incontinence) is found to be associated with 673 drugs and 827 conditions by eHealthMe. Check the latest studies of Affect lability.

What is Enterocolitis?

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon) is found to be associated with 670 drugs and 730 conditions by eHealthMe. Check the latest studies of Enterocolitis.

On Jun, 18, 2026

1 person who has Affect Lability and Enterocolitis is studied.

Would you have Enterocolitis when you have Affect lability?

Gender of people who have Affect Lability and experienced Enterocolitis *:

female: 0.0 %
male: 100 %

Common drugs taken by these people *:

Stavudine: 1 person, 100.00%
Lamivudine: 1 person, 100.00%
Kaletra: 1 person, 100.00%
Clonazepam: 1 person, 100.00%
Bactrim: 1 person, 100.00%

Common symptoms for these people *:

Subileus: 1 person, 100.00%
Nausea And Vomiting: 1 person, 100.00%
Nausea (feeling of having an urge to vomit): 1 person, 100.00%
Abdominal Pain: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Enterocolitis?

- Check whether Enterocolitis is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Affect lability (13,491 reports)
Enterocolitis (7,684 reports)

All the drugs that are associated with Enterocolitis:

Enterocolitis (670 drugs)

All the conditions that are associated with Enterocolitis:

Enterocolitis (730 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Enterocolitis and Affect lability, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.